VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,220,493 | -31.7% | 7,651,176 | -0.5% | 0.00% | -50.0% |
| Q2 2023 | $23,756,498 | -71.7% | 7,688,187 | -50.8% | 0.00% | -50.0% |
| Q1 2023 | $84,068,266 | +58.6% | 15,626,072 | +96.0% | 0.00% | -20.0% |
| Q4 2022 | $53,003,898 | +318.6% | 7,970,511 | +150.5% | 0.01% | +400.0% |
| Q3 2022 | $12,661,000 | -20.0% | 3,181,235 | -0.1% | 0.00% | -50.0% |
| Q2 2022 | $15,833,000 | -17.7% | 3,185,653 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $19,240,000 | -48.0% | 3,185,565 | +0.1% | 0.00% | -33.3% |
| Q4 2021 | $36,968,000 | -26.4% | 3,181,463 | -0.7% | 0.00% | -25.0% |
| Q3 2021 | $50,260,000 | -21.3% | 3,205,394 | -10.0% | 0.00% | -20.0% |
| Q2 2021 | $63,861,000 | -56.5% | 3,561,191 | -3.2% | 0.01% | -61.5% |
| Q1 2021 | $146,673,000 | – | 3,677,048 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |